HUM Humana Inc

Price (delayed)

$369.21

Market cap

$44.33B

P/E Ratio

34.67

Dividend/share

$3.54

EPS

$10.65

Enterprise value

$52.04B

?
Relative Growth: Rel. Growth: 55
Relative Strength: Rel. Strength: 91
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 37

Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make ...

Highlights
The revenue has increased by 18% year-on-year and by 6% since the previous quarter
HUM's gross profit is up by 7% year-on-year and by 3.5% since the previous quarter
The EPS has declined by 19% year-on-year but it is up by 13% since the previous quarter
The net income has declined by 19% year-on-year but it has grown by 13% since the previous quarter
HUM's price to earnings (P/E) is 54% higher than its 5-year quarterly average of 22.2 and 29% higher than its last 4 quarters average of 26.5
HUM's debt is up by 13% year-on-year and by 2.2% since the previous quarter

Key stats

What are the main financial stats of HUM

HUM stock price

How has the Humana stock price performed over time
Intraday
1.47%
1 week
-3.13%
1 month
-6.94%
1 year
49.32%
YTD
44.15%
QTD
-7.05%

Financial performance

How have Humana's revenue and profit performed over time
Revenue
$145.68B
Gross profit
$19.89B
Operating income
$2.71B
Net income
$1.28B
Gross margin
13.7%
Net margin
0.9%
HUM's net margin is down by 31% year-on-year but it is up by 13% since the previous quarter
HUM's operating margin is down by 30% year-on-year but it is up by 6% since the previous quarter
The net income has declined by 19% year-on-year but it has grown by 13% since the previous quarter
The operating income has contracted by 18% YoY but it has grown by 11% from the previous quarter

Price vs fundamentals

How does HUM's price correlate with its fundamentals

Growth

What is Humana's growth rate over time

Valuation

What is Humana stock price valuation
P/E
34.67
P/B
2.31
P/S
0.3
EV/EBIT
22.81
EV/EBITDA
17
EV/Sales
0.36
HUM's price to earnings (P/E) is 54% higher than its 5-year quarterly average of 22.2 and 29% higher than its last 4 quarters average of 26.5
The EPS has declined by 19% year-on-year but it is up by 13% since the previous quarter
The price to book (P/B) is 26% higher than the last 4 quarters average of 1.8 but 19% lower than the 5-year quarterly average of 2.8
The equity is up by 5% year-on-year and by 3.4% since the previous quarter
The P/S is 50% above the last 4 quarters average of 0.2 but 40% below the 5-year quarterly average of 0.5
The revenue has increased by 18% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Humana business performance
The return on sales has declined by 27% year-on-year but it is up by 7% since the previous quarter
The company's return on assets fell by 25% YoY but it rose by 9% QoQ
The return on equity has declined by 23% year-on-year but it has grown by 11% since the previous quarter
Humana's return on invested capital has decreased by 18% YoY but it has increased by 13% QoQ

Dividends

What is HUM's dividend history
DPS
$3.54
Dividend yield
0.96%
Payout ratio
33.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Humana financials performed over time
Humana's total assets is 51% more than its total liabilities
HUM's total liabilities is up by 18% year-on-year and by 3.5% since the previous quarter
The quick ratio has decreased by 15% YoY but it has increased by 2.4% from the previous quarter
HUM's debt is 24% smaller than its equity
HUM's debt is up by 13% year-on-year and by 2.2% since the previous quarter
Humana's debt to equity has increased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.